As of 4:00pm ET
| +0.12 / +0.41%|
AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. Its pipeline consists of azd 0156, medi 573, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta. The company distributes its products under the following brands: Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. AstraZeneca was founded on April 6, 1999 and is headquartered in London, the United Kingdom.
|Pascal Soriot||Chief Executive Officer & Executive Director|
|Pam P. Cheng||Executive VP-Operations & Information Technology|
|Marc Dunoyer||Chief Financial Officer & Executive Director|
|Sean Bohen||Chief Medical Officer & Executive Vice President|
|Katarina Ageborg||Chief Compliance Officer|